◼ Archived
Business
🔮 fades
Novo Nordisk sues Eli Lilly, alleging misleading GLP-1 advertising
Novo Nordisk has launched a legal offensive against Eli Lilly, alleging that the competitor's GLP-1 weight-loss drug advertising is deceptive.